F19.980 Other psychoactive substance use, unspecified with psychoactive substance-induced anxiety disorder

Name of the Condition

• Other Psychoactive Substance Use, Unspecified with Psychoactive Substance-Induced Anxiety Disorder
• ICD-10 Code: F19.980

Summary

This condition involves the use of a psychoactive substance not classified under more specific categories (e.g., alcohol, cannabis, opioids) where the substance is unidentified, and there is a co-occurring psychoactive substance-induced anxiety disorder. It is classified as "unspecified" when the exact agent is unknown or not documented, and "with psychoactive substance-induced anxiety disorder" indicates the presence of anxiety symptoms directly caused by the substance use.

Causes

The condition may result from experimentation, recreational use, or habitual consumption of various psychoactive substances. These substances can alter perception, mood, cognition, or behavior, though the specific agent is not specified. The induced anxiety arises from the substance’s effects on the central nervous system or other bodily systems.

Risk Factors

• Peer pressure or cultural acceptance of substance use.
• Stressful life circumstances or co-occurring mental health conditions (e.g., anxiety, depression).
• Availability of and access to psychoactive substances.

Symptoms

Symptoms vary based on the substance but may include altered perception, mood swings, impaired judgment, or changes in behavior. Induced anxiety symptoms may include excessive worry, restlessness, or panic-like episodes. The exact presentation depends on the unidentified psychoactive agent.

Diagnosis

Diagnosis typically involves a clinical assessment, including patient history and behavioral observations. Lab tests may be used if the substance identity is unknown, though no specific tests are standard. The presence of anxiety symptoms is evaluated to confirm the induced disorder.

Treatment Options

• Counseling and Behavioral Therapies: Aim to address substance use behaviors and manage anxiety symptoms.
• Medications: May include anxiolytics or other agents to alleviate anxiety, depending on the substance involved.
• Support Groups: Provide community-based support for recovery.

Prognosis and Follow-Up

Prognosis depends on the severity of substance use and anxiety symptoms, as well as adherence to treatment. Regular follow-up is important to monitor for relapse or worsening symptoms. Long-term recovery often requires ongoing support.

Complications

• Worsening anxiety or development of additional substance-induced disorders.
• Social or occupational impairment due to substance use.
• Increased risk of overdose or other substance-related harm.

Lifestyle & Prevention

• Avoiding known psychoactive substances and environments where they are used.
• Managing stress through healthy coping mechanisms (e.g., exercise, mindfulness).
• Seeking early intervention for mental health concerns.

When to Seek Professional Help

Seek help if substance use interferes with daily life, or if anxiety symptoms become severe or persistent. Immediate care is needed for overdose or acute distress.

Tips for Medical Coders

Document the unspecified psychoactive substance and confirm the presence of substance-induced anxiety disorder. Ensure clinical notes support the diagnosis and specify if the anxiety is directly attributable to the substance use.